+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

P-cadherin as prognostic factor for loco-regional relapse in breast cancer



P-cadherin as prognostic factor for loco-regional relapse in breast cancer



Acta Medica Portuguesa 25(2): 97-105



Breast cancer is the most frequent malignant tumor and the leading cause of cancer death in women in Portugal. Due to its relation to an increase in distant metastasis and subsequent death, loco-regional relapse is one major concern in breast cancer women. Several classic prognostic factors as tumour size, nodal stage, histological grade, HER2 status and hormonal receptors have been identified as the most important factors for determining loco-regional relapse, disease free and overall survival. However, there is heterogeneity in prognosis and tumor behaviour in patients with identical disease staging and a similar pattern of expression of known molecular markers, hence the need to discover new prognostic factors. One of the possibilities is P-cadherin, already described by researchers as a possible independent marker of prognosis in breast cancer. The aim of this work was to study in a retrospective series of patients the correlation of P-cadherin expression with loco-regional recurrence in breast cancer women. We analyzed the clinical records of 1432 consecutive patients with breast cancer and treated in a University Hospital over a 10 year period. Patients with loco-regional relapse (n=101) without prior or simultaneous distant disease were selected as case group. Control group consisted of patients with more than 10 years follow-up and without disease progression. For both groups demographic, clinical, pathological and molecular markers were analyzed. Tissue micro-arrays were constructed to study P-cadherin expression from 86 tumors with available paraffin embedded blocks. Mean time to recurrence was 41 months and mean survival time after recurrence was 33 months, with a 5-year survival rate of 55%. Tumour size, nodal status and histological grade were identified as independent markers of prognosis. P-cadherin was associated with higher histological grades and hormone negative tumours. P-cadherin was identified as an independent prognostic marker for disease free survival, but not for overall survival. P-cadherin was related to other known factors of worse prognosis and had an independent relation to disease-free survival. P-cadherin might constitute a novel therapeutic target, but its real biological value is yet to be determined. Doubt persists whether it is an independent marker of tumour behaviour or only a surrogate marker of a set of clinical and molecular features related with worse prognosis.

(PDF emailed within 1 workday: $29.90)

Accession: 054831147

Download citation: RISBibTeXText

PMID: 22985920


Related references

Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (< 40 years) women treated with breast conserving surgery first. Radiotherapy and Oncology 82(3): 272-280, 2007

Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen. European Journal of Surgical Oncology 37(12): 1051-1058, 2012

Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations. La Semaine des Hopitaux 60(2): 91-96, 1984

Loco-regional recurrences after mastectomy in breast cancer: Prognostic factors and implications for postoperative irradiation. Radiotherapy & Oncology 50(3): 267-275, March, 1999

Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer. Geburtshilfe und Frauenheilkunde 75(7): 710-718, 2015

Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012. Breast 22(5): 902-907, 2014

18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: association of loco‑regional SUVmax with classical prognostic factors. Quarterly Journal of Nuclear Medicine and Molecular Imaging 58(1): 66-73, 2014

Classical prognostic factors for survival and loco-regional control in breast cancer patients treated with radical mastectomy alone. Acta Oncologica (stockholm). 33(7): 759-765, 1994

The expression of E-cadherin as a prognostic factor in breast cancer. Oncology Reports 4(2): 401-405, 1997

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer. Bmc Cancer 5(): 62-62, 2005

Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. American Journal of Pathology 152(3): 721-728, 1998

Age as a prognostic factor for breast and regional nodal recurrence following breast conserving surgery and irradiation in stage I and II breast cancer. International Journal Of Radiation Oncology Biology Physics. 27(5): 1045-1050, 1993